Chantal Tallaksen

Multi-system neurological disease is common in patients with OPA1 mutations

Patrick Yu‐Wai‐Man, Philip G. Griffiths, Gráinne S. Gorman et al. · Brain · 2010 · 447 citations · Full text

Medicine, Genetics, Neurology +16

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

Paraskevi Zisimopoulou, Panagiota Evangelakou, John Tzartos et al. · Journal of Autoimmunity · 2013 · 324 citations · Full text

Life Sciences, Endocrinology, Immunology +11

Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration

Giovanni Stévanin, Hamid Azzedine, Paola S. Denora et al. · Brain · 2007 · 253 citations

Life Sciences, Genetics, Neurology +17

Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study

Anne Kjersti Erichsen, Jeanette Koht, Asbjørg Stray‐Pedersen et al. · Brain · 2009 · 209 citations

Life Sciences, Genetics, Neurology +13

The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis

Amel Meraouna, Géraldine Cizeron-Clairac, Rozen Le Panse et al. · Blood · 2006 · 169 citations

Life Sciences, Immunology, Molecular Biology +10